Dementias with Lewy bodies;Demenzen mit Lewy-Körperchen

Fortschritte der Neurologie Psychiatrie

Volumn 70, Issue 9, 2002, Pages 476-494

  Lang, C J G ^a   Bergmann, M ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institut für Klinische Neuropathologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DONEPEZIL; HOMOVANILLIC ACID; OLANZAPINE; ONDANSETRON; RISPERIDONE; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; ARTICLE; BRAIN TOMOGRAPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOKINESIA; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; HUMANS; LEWY BODY DISEASE; MIDDLE AGED;

EID: 0036739770     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33858     Document Type: Article

References (155)

1. Luis CA, Mittenberg W, Gass CS, Duara R. Diffuse Lewy body disease: Clinical, pathological, and neuropsychological review. Neuropsychol Rev 1999; 9: 137-150
2. Papka M, Rubio A, Schiffer RB. A review of Lewy body disease, an emerging concept of cortical dementia. J Neuropsychiatry Clin Neurosci 1998; 10: 267-279
3. Robles A. Demencia con cuerpos de Lewy: nuevas aportaciones a su conocimiento clínico. Rev Neurol 2000; 30: 701-707
4. Farina E, Cannatà AP, Mariani C. Non-Alzheimer forms of cortical degeneration: Frequency in clinical practice and clinical report of six cases. Aging Clin Exp Res 1996; 8: 235-242
5. Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies. Cambridge, UK: Cambridge University Press, 1996
6. McKeith IG. Clinical Lewy body syndromes. Ann N Y Acad Sci 2000; 920: 1-8
7. Hansen LA. Dementia with Lewy bodies. In: Terry RD, Katzman R, Bick KL, Sisodia SS (Hrsg). Alzheimer Disease. 2. Aufl Philadelphia, USA: Lippincott Williams & Wilkins, 1999: 181-185
8. Lang C. Demenzen: Diagnose und Differentialdiagnose. London: Chapman & Hall, 1994: 152-167
9. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using antiubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989; 52: 1236-1247
10. Lennox GG, Lowe JS. Dementia with Lewy bodies. Baillieres Clin Neurol 1997; 6: 147-166
11. Jackson M, Lennox G, Balsitis M, Lowe J. Lewy body dysphagia. J Neurol Neurosurg Psychiatry 1995; 58: 756-757
12. Lennox GG, Lowe JS. Dementia with Lewy bodies. In: Markesberry WR (Hrsg). Neuropathology of dementing disorders. London: Arnold, 1998: 181-192
13. Mori H, Yoshimura M, Tomonaga M, Yamanouchi H. Progressive supranuclear palsy with Lewy bodies. Acta Neuropathol (Berlin) 1986; 71: 344-346
14. Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 1991; 54: 159-161
15. Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC. Meige syndrome in the spectrum of Lewy body disease. Neurology 1994; 44: 1432-1436
16. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990; 40: 1-8
17. Galasko D, Salmon DP, Thal LJ. The nosological status of Lewy body dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 21-32
18. Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 1998; 8: 299-324
19. McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin 2000; 18: 865-902
20. Förstl H. The Lewy body variant of Alzheimer's disease: clinical, pathophysiological and conceptual issues. Eur Arch Psychiatry Clin Neurosci 1999; 249 (Suppl 3): III/64-III/67
21. Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol 2000; 57: 713-719
22. Byrne EJ, Lowe J, Godwin-Austen RB, Arie T, Jones R. Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies. Lancet 1987; 1 (8531): 501
23. Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (Berl) 1992; 83: 525-529
24. Goldman JE, Yen SH, Chiu FC, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983; 221: 1082-1084
25. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993; 52: 183-191
26. Lowe J. Lewy bodies. In: Calne DB (Hrsg). Neurodegenerative Diseases. Philadelphia: Saunders, 1994: 51-69
27. Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 2002; 58: 179-185
28. Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billet M, Landon M, Mayer RJ. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmatic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 1988; 155: 9-15
29. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 1990; 161: 153-160
30. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ. Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 1992; 166: 61-68
31. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993; 3: 55-65
32. Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis I(L. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol 2000; 57: 1145-1150
33. Stern Y, Jacobs D, Goldman J, Gomez-Tortosa E, Hyman BT, Liu Y, Troncoso J, Marder K, Tang MX, Brandt J, Albert M. An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. Arch Neurol 2001; 58: 460-465
34. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55: 44-52
35. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM-Y, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000; 54: 1916-1921
36. Anonymus. Obituaries. Frederic H. Lewey, M.D. 1885-1950. Arch Neurol Psychiatry 1951; 66: 114-115
37. Gibb WRG, Poewe WH. The centenary of Friederich H. Lewy 1885-1950. Neuropathol Appl Neurobiol 1986; 12: 217-221
38. Cohn DF. Biographical note on F. H. Lewy. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: XXV-XXIX
39. Schiller F. Fritz Lewy and his bodies. J History Neurosci 2000; 9: 148-151
40. Holdorff B. Friedrich Heinrich Lewy (1885-1950) and his work. J Hist Neurosci 2002; 11: 19-28
41. Lewy FH. I. Pathologische Anatomie. In: Forster E, Lewy FH. Paralysis agitans. In: Lewandowsky M (Hrsg). Handbuch der Neurologie. Dritter Band. Spezielle Neurologie 11. Berlin: Springer, 1912: 920-933
42. Lewy FH. Zur pathologischen Anatomie der Paralysis agitans. Dt Zsch Nervenheilk 1914; 50: 50-55
43. Lewy FH. Die Lehre vom Tonus und der Bewegung. Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis agitans. Berlin: Springer, 1923
44. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmatic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20: 237-244
45. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse Lewy body disease: progressive dementia with abundant Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 1984; 3: 185-192
46. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-717
47. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22: 911-922
48. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Inc EPG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124
49. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45-50
50. Londos E, Passant U, Brun A, Gustafson L. Clinical Lewy body dementia and the impact of vascular components. Int J Geriatr Psychiatry 2000; 15: 40-49
51. McKeith I, O'Brien J. Dementia with Lewy bodies. Austr N Z J Psychiatry 1999; 33: 800-808
52. Forno LS, Langston JW. The amygdala-hippocampal region: a predilection site for Lewy bodies. J Neuropathol Exp Neurol 1988; 47: 354
53. Lennox G, Lowe J, Byrne EJ, Landon M, Mayer RJ, Godwin-Austen. Diffuse Lewy body disease. Lancet 1989; 1(8633): 323-324
54. Dickson DW, Feany MB, Yen SH, Mattiace LA, Davies P. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. J Neural Transm Suppl 1996; 47: 31-46
55. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175
56. Cercy SP, Bylsma FW. Lewy bodies and progressive dementia: a critical review and meta-analysis. J Int Neuropsychol Soc 1997; 3: 179-194
57. Papka M, Rubio A, Schiffer RB, Cox C. Lewy body disease: can we diagnose it? J Neuropsychiatry Clin Neurosci 1998; 10: 405-412
58. Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996; 47: 1148-1152
59. Rosenberg CK, Cummings TJ, Saunders AM, Widico C, McIntyre LM, Hulette CM. Dementia with Lewy bodies and Alzheimer's disease. Acta Neuropathol 2001; 102: 621-626
60. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995; 37: 110-112
61. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950-1951
62. Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000; 54: 407-411
63. Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM. Mitochondrial DNY haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000; 55: 302-304
64. Lowe JS, Mayer RJ, Landon M. Pathological significance of Lewy bodies in dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies. Cambridge, UK: Cambridge University Press, 1996: 195-203
65. Cummings JL. Lewy body diseases with dementia: Pathophysiology and treatment, Brain Cogn 1995; 28: 266-280
66. Liberini P, Valerio A, Memo M, Spano P. Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? Trends Pharmacol Sci 1996; 17: 155-160
67. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 1995; 64: 385-395
68. Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurol Scand 2000; Suppl 176: 34-41
69. Sabbagh MN, Reid RT, Hansen LA, Alford M, Thal LJ. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies. J Neural Transm 2001; 108: 1149-1157
70. Weiner MF, Risser RC, Cullum M, Honig L, White III C, Speciale S, Rosenberg RN. Alzheimer's disease and its Lewy body variant: A clinical analysis of postmortem verified cases. Am J Psychiatry 1996; 153: 1269-1273
71. Leverenz JB, Miller MA, Dobie DJ, Peskind ER, Raskind MA, Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies. Neurobiol Aging 2001; 22: 555-561
72. Leake A, Perry EK, Perry RH,Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: Comparison with Parkinson's disease and severity correlations. Biol Psychiatry 1991; 29: 357-364
73. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK. Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: 1050-1058
74. Markesberry WK. Neuropathology of dementing disorders. London: Arnold, 1998: 64
75. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 2001; 102: 355-363
76. de Vos RAI, Jansen ENH, Stam FC, Ravid R, Swaab DF. 'Lewy body disease': clinico-pathologial correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995; 97: 13-22
77. Chu CT, Caruso JL, Cummings TJ, Ervin J, Rosenberg C, Hulette CM. Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia. Mod Pathol 2000; 13: 420-426
78. Hansen LA, Masliah E, Quijada-Fawcett S, Rexin D. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Neurosci Lett 1991; 129: 269-272
79. Hansen LA. Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 204-211
80. Del Ser T, Hachinski V, Merskey H, Munoz DG. Clinical and pathological features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load. Alzh Dis Assoc Disord 2001; 15: 31-44
81. Broe M, Shepherd CE, Milward EA, Halliday GM. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2001; 101: 616-624
82. Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch Neurol 2000; 57: 817-822
83. Lopez OL, Hamilton RL, Becker T, Wisniewski S, Kaufer DI, DeKosky ST. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000; 54: 1780-1787
84. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 1994; 165: 324-332
85. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000; 54: 1616-1624
86. Gomez-Isla T, Growdon WB, McNamara M, Newell K, Gomez-Tortosa E, Hedley-White ET, Hyman BT, Clinicopathological correlates in temporal cortex in dementia with Lewy bodies. Neurology 1999; 53: 2003-2009
87. Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999; 53: 1974-1982
88. Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies, Arch Neurol 2000; 57: 347-351
89. Serby M, Samuels SC. Visual hallucinations and dementia with Lewy bodies. Arch Neurol 2000; 57: 1792
90. Burns A. Clinical features of patients with Alzheimer's disease and Lewy bodies. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies. Cambridge, UK: Cambridge University Press, 1996: 46-56
91. McShane R, Keene J, Gedling K, Hope T. Hallucinations, cortical Lewy body pathology, cognitive function and neuroleptic use in dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies. Cambridge, UK: Cambridge University Press, 1996: 85-98
92. Förstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease. Br J Psychiatry 1993; 162: 385-392
93. Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease, Neurology 1999; 52: 1839-1844
94. Lopez OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, DeKosky ST. Predictors of progression in patients with AD and Lewy bodies. Neurology 2000; 54: 1774-1779
95. Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997; 48: 376-380
96. 96 Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996; 31: 166-175
97. Gnanalingham KK, Byrne EJ, Thornton A. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 243-252
98. Imamura T, Hirono N, Hashimoto M, Kazui H, Tanimukai S, Hanihara T, Takahara A, Mori E. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol 2000; 7: 77-79
99. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001; 70: 739-743
100. Daum RF, Sekinger B, Kobal G, Lang CJG. Riechprüfung mit "sniffin' sticks" zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt 2000; 71: 643-650
101. Mann DM. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001; 70: 720-721
102. Watanabe H, leda T, Katayama T, Takeda A, Aiba I, Doyu M, Hirayama M, Sobue G. Cardiac 1231-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70: 781-783
103. Ballard C, Lowery K, Harrison R, McKeith IG. Noncognitive symptoms in Lewy body dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 67-84
104. Beck BJ. Neuropsychiatric manifestations of diffuse Lewy body disease. J Geriatr Psychiatry Neurol 1995; 8: 189-196
105. Filley CM. Neuropsychiatric features of Lewy body disease. Brain Cogn 1995; 28: 229-239
106. Ferman TJ, Boeve BF, Smith GE, Silber MH, Kokmen E, Petersen RC, Ivnik RJ. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology 1999; 23: 951-957
107. Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998; 51: 363-370
108. Byrne EJ. The nature of cognitive decline in Lewy body dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 57-66
109. Galloway PG, Mulvihill P, Perry G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 1992; 140: 809-822
110. Salmon DP, Galasko D. Neuropsychological aspects of Lewy body dementia. In: Perry R, McKeith 1, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 96-113
111. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996b; 31: 148-165
112. Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70: 483-488
113. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 1996; 347: 696-697
114. Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, Tanimukai S, Kazui H, Hanihara T. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57: 489-493
115. Walker Z, Allen RL, Shergill S, Katona CLE. Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry 1997; 170: 156-158
116. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. Cognitive profiles of autopsy-confirmed Lewy body variant vs. pure Alzheimer disease. Arch Neurol 1998; 55: 994-1000
117. Sahgal A. The neuroanatomical basis of cognitive deficits in Lewy body dementia. In: Perry R, McKeith I, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 114-131
118. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 1998; 51: 351-357
119. Galasko DR, Gould RL, Abramson IS, Salmon DP. Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med 2000; 19: 1421-1432
120. Ballard C, Patel A, Oyebode F, Wilcock G. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. Age Ageing 1996; 25: 209-213
121. Kanemaru K, Kameda N, Yamanouchi H. Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies. Neurology 2000; 54: 1875-1876
122. Tschampa HJ, Schulz-Schaeffer W, Wiltfang J, Poser S, Otto M, Neumann M, Kretzschmar HA. Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies. Neurology 2001; 56: 576
123. Briel RC, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66: 401-403
124. Tschampa HJ, Neumann M, Zerr I, Henkel K, Schröter A, SchulzSchaeffer WJ, Steinhoff BJ, Kretzschmar HA, Poser S. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-39
125. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998; 51: 357-362
126. Lippa CF, Johnson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann Neurol 1998; 43: 102-106
127. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies. Neurology 2000; 54: 1304-1309
128. Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001; 12: 198-205
129. Middelkoop HAM, van der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, Ballard C, McKeith IG, O'Brien JT. Dementia with Lewy bodies and AD are not associated with occipital atrophy on MRI. Neurology 2001; 57: 2117-2120
130. Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N, Shimomura T, Hashimoto M, Tanimukai S, Kazui H, Mori E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett 1997; 235: 49-52
131. Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T, Sasaki M, Mori E. Occipital glucose metabolism in dementia with Lewy bodies with and without Parkinsonism: A study using positron emission tomography. Dementia Geriatr Cogn Disord 2001; 12: 194-197
132. 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nuclear Med 1997; 24: 320-325
133. Velakoulis D, Lloyd JH. The role of SPECT scanning in a neuropsychiatry unit. Aust N Z J Psychiatry 1998; 32: 511-522
134. 99mTcHMPAO single-photon emisson computed tomography study of Lewy body disease. J Neurol 1997; 244: 349-359
135. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643-649
136. Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G, Poewe W, Wenning GK. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Eur J Nucl Med 2001; 28: 1523-1528
137. Graham C, Ballard C, Saad K. Variables which distinguish patients fulfilling clinical criteria for dementia with Lewy bodies from those with Alzheimer's disease. Int J Geriatr Psychiatry 1997; 12: 314-318
138. Hely MA, Reid WG, Halliday GM, McRitchie DA, Leicester J, Joffe R, Brooks W, Broe GA, Morris JG. Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 60: 531-538
139. Lennox GG, Lowe JS. The clinical diagnosis and misdiagnosis of Lewy body dementia. In: Perry R, McKeith 1, Perry E (Hrsg). Dementia with Lewy Bodies Cambridge, UK: Cambridge University Press, 1996: 9-20
140. Campbell S, Stephens S, Ballard C. Dementia with Lewy bodies: clinical features and treatment. Drugs Aging 2001; 18: 397-407
141. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH. An evaluation of the predictive validity and interrater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994; 44: 872-877
142. Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998; 351: 1032-1033
143. McKeith IG, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, CicinSain A, Ferrara R, Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036
144. Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, Butler S, Wilkinson D, Woolford J, Waite J, McKeith IG. Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr 2001; 13: 199-205
145. Skjerve A, Nygaard HA. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int J Geriatr Psychiatry 2000; 15: 1147-1151
146. Rojas-Fernandez CH. Successful use of donepezil for the treatment of dementia with Lewy bodies. Ann Pharmacother 2001; 35: 202-205
147. Lebert F, Pasquier F, Souliez L, Petit H. Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 1998; 13: 516-519
148. Querfurth HW, Allam GJ, Geffroy MA, Schiff HB, Kaplan RF. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord 2000; 11: 314-321
149. Byrne EJ, Burns A, Waite J. Neuroleptic sensitivity in dementia with cortical Lewy bodies. Br Med J 1992; 305: 1158-1159
150. McKeith IG, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992; 305: 673-678
151. Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, MCKeith IG. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999; 14: 459-466
152. Burke WJ, Pfeiffer RF, McComb RD. Neuroleptic sensitivity to clozapine in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 1998; 10: 227-229
153. Lowery K, Mynt P, Aisbett J, Dixon L, O'Brien J, Ballard C. Depression in the careers of dementia sufferers: a comparison of the careers of patients suffering from dementia with Lewy bodies and the careers of patients with Alzheimer's disease. J Affect Disord 2000; 59: 61-65
154. Lang CJG, Bozikake-Leisch E, Spambalg M, Bartelsen P, Treig T. Psychometrische Sprachstudien bei Alzheimer-Demenz mit dem Aachener Aphasie-Test. Nervenarzt 1991; 62: 621-628
155. McKeith IG. Dementia with Lewy bodies. Br J Psychiatry 2002; 180: 144-147